Skip to main content

Peer Review reports

From: Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial

Original Submission
8 Feb 2023 Submitted Original manuscript
21 Feb 2023 Author responded Author comments - saeed erfanpoor
Resubmission - Version 2
21 Feb 2023 Submitted Manuscript version 2
15 May 2023 Reviewed Reviewer Report
24 Jun 2023 Reviewed Reviewer Report
10 Jul 2023 Author responded Author comments - saeed erfanpoor
Resubmission - Version 3
10 Jul 2023 Submitted Manuscript version 3
21 Jul 2023 Reviewed Reviewer Report
2 Nov 2023 Reviewed Reviewer Report
30 Nov 2023 Author responded Author comments - saeed erfanpoor
Resubmission - Version 4
30 Nov 2023 Submitted Manuscript version 4
18 Dec 2023 Reviewed Reviewer Report
4 Feb 2024 Author responded Author comments - saeed erfanpoor
Resubmission - Version 5
4 Feb 2024 Submitted Manuscript version 5
Publishing
12 Feb 2024 Editorially accepted
20 Feb 2024 Article published 10.1186/s12916-024-03295-1

You can find further information about peer review here.

Back to article page